CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 46,620 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −2,621 | $70.39 | $184K | 43,999 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −2,267 | $71.07 | $161K | 41,732 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −112 | $72.37 | $8K | 41,620 |
| 2025-03-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 144,497 | ||
| 2025-03-03 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes | −616 | $72.10 | $44K | 41,620 |
| 2025-02-28 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Shares withheld for taxes | −470 | $73.02 | $34K | 42,236 |
| 2025-02-27 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award | +14,484 | 42,706 | ||
| 2025-02-27 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Grant or award · Stock Option (right to buy) | +48,357 | 48,357 | ||
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 33,222 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −571 | $87.77 | $50K | 32,651 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −635 | $89.09 | $57K | 32,016 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,755 | $89.95 | $158K | 30,261 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −1,784 | $91.05 | $162K | 28,477 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −255 | $91.71 | $23K | 28,222 |
| 2025-02-05 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 149,497 | ||
| 2025-01-06 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +5,000 | $21.41 | $107K | 33,222 |
| 2025-01-06 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −954 | $84.86 | $81K | 32,268 |
| 2025-01-06 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −3,921 | $85.73 | $336K | 28,347 |
| 2025-01-06 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −125 | $86.52 | $11K | 28,222 |
Page 1 of 6 · 115 trades